Smartsheet에 대한 매도 수량은 투자자에게 Smartsheet의 주식 하락에 베팅하는 정도를 알려줍니다. 매도 수량 데이터는 2주마다 업데이트됩니다.

Smartsheet (NYSE:SMAR) 주식, 공매도 수량 보고

Smartsheet

Smartsheet is a provider of collaborative work management software delivered via a cloud-based, software-as-a-service model. The firm's solution offers scalable, dynamic tools to improve the efficiency of project and process management across countless use cases. Smartsheet's offering supports workflow management across teams, provides real-time visibility into projects, and reporting and automation capabilities. The firm generates revenue via software subscriptions on a per-user basis, and incremental charges for added platform capabilities.

Earnings

News

Movers

SMAR

스마트시트(NYSE:SMAR)의 주가는 회사의 1분기 재무 결과에 뒤이어 수요일 시간외 세션에서 상승했다. 이 보고서 요약은 다음과 같다. 1분기 매출: 2억 6,300만 달러, 예상치 2억 5,828만 달러보다 높음 1분기 주당순이익 (EPS): 32센트, 예상치 27센트보다 높음

스마트시트: 1분기 실적 호조와 긍정적인 연간 전망에 주가 급등

Smartsheet Inc

SmartCash

SmartCredit Token

SMAREGI INC by SMAREGI INC

SMARTSHARES AUS MDCAP by SMARTSHARES AUSTRALIAN MID CAP.

SMARTONE TELECOMM HLDGS by SmarTone Telecommunications Holdings Ltd.

SmarTone Telecommunications Holdings Ltd

SMART CANNABIS CORP by Smart Cannabis Corp.

Smart Cannabis Corp

SMART CARD MKTG SYS INC by Smart Card Marketing Systems, Inc.

Smart Card Marketing Systems Inc

Smart Closet Inc

SMART DECISION INC by SMART DECISION INC.

Smart Decision Inc

Smart Digital Group Ltd

Smart Employee Benefits Inc

Smart Eye AB

Smart Logistics Global Ltd

Smart MFG

Smart Parking Ltd

Smart Powerr Corp

Smart Sand Inc

Smart Share Global Limited - American Depositary Shares

Smart Share Global Ltd

SMART VENTURES INC by Smart Ventures, Inc.

Smart Ventures Inc

SMART FOR LIFE INC by Smart for Life, Inc.

Smart for Life Inc

SmartCentres Real Estate Investment Trust Trust Units Variable Voting

SmartCentres Real Estate Investment Trust

SMARTCOOL SYSTEMS INC ORD by SmartCool Systems, Inc.

SmartCool Systems Inc

SmartETFs Asia Pacific Dividend Builder ETF

SmartETFs Dividend Builder ETF

SmartETFs Smart Transportation & Technology ETF

SmartETFs Sustainable Energy II ETF

SmartFinancial Inc

SmartKem Inc

SmartMetric Inc

SmartRent Inc

SMARTFIT ESCOLA U/ADR by SMARTFIT ESCOLA DE GINASTICA E DANCA S.A.

Smartfit Escola DE Ginastica E Danca SA

SMARTGROUP CORP LTD by Smartgroup Corp Ltd.

Smartgroup Corporation Ltd

Smartlands Network

SMARTOPTICS GROUP AS by SMARTOPTICS GROUP AS

Smartoptics Group AS

SMARTSTOP SELF STRGE T by Smartstop Self Storage REIT Inc

Smartstop Self Storage REIT Inc

SMARTSTOP SELF STRGE REIT by Smartstop Self Storage REIT Inc

smARTOFGIVING

Trading Ideas

PXDT

Pixie Dust Technologies Shares Halted On Circuit Breaker To The Upside, Stock Now Up 108.9%

Goldman Sachs analyst Mike Niehuser maintains Nu Holdings (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NU#NYSE">NU</a>) with a Buy and raises the price target from $17 to $19.

Price Target

Analyst Ratings

Goldman Sachs Maintains Buy on Nu Holdings, Raises Price Target to $19

Canaccord Genuity analyst John Newman maintains BioNTech (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BNTX#NASDAQ">BNTX</a>) with a Buy and maintains $171 price target.

BNTX

Canaccord Genuity Maintains Buy on BioNTech, Maintains $171 Price Target

RBC Capital analyst Douglas Miehm reiterates Oncolytics Biotech (TSX:<a class="ticker" href="https://www.benzinga.com/stock/ONC#TSX">ONC</a>) with a Outperform and maintains C$6 price target.

Reiteration

ONCY

TSX:ONC

RBC Capital Reiterates Outperform on Oncolytics Biotech, Maintains C$6 Price Target

Exxon Mobil Corp (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XOM#NYSE">XOM</a>) shares are trading higher by roughly 5% during November after Donald Trump's win in the <a href="https://www.benzinga.com/economics/macro-economic-events/24/11/41772701/trumps-historic-return-7-ways-his-second-term-could-impact-the-us-economy">presidential election</a>, as investors anticipate a more favorable regulatory and economic environment for the oil and gas sector.
Trump's administration is expected to prioritize fossil fuel production, potentially reversing recent policies on environmental restrictions and supporting domestic energy expansion, which could directly benefit Exxon's extensive U.S. operations. 
Trump's stance on reducing regulations in the energy sector could make it easier and more cost-effective for Exxon to expand drilling projects, especially in U.S. shale regions like the Permian Basin, where the company has invested heavily in recent years.
Read Also: <a href="https://www.benzinga.com/tech/24/11/41973572/ray-dalios-bridgewater-cuts-stake-in-microsoft-stock-by-20-is-big-tech-losing-its-shine">Ray Dalio&#8217;s Bridgewater Cuts Stake In Microsoft Stock By 20% – Is Big Tech Losing Its Shine?</a>
What To Know: One anticipated shift under Trump's policies would be a rollback of regulations tied to carbon emissions, methane leaks, and drilling permits, which had increased compliance costs for companies like Exxon. 
With eased regulatory pressures, Exxon would have greater flexibility to explore and develop new oil and gas fields without facing stringent environmental compliance costs, potentially boosting production levels and profitability. 
Additionally, Trump's proposal to withdraw from the Paris Climate Agreement and possibly undo green energy subsidies could slow the U.S. transition to renewables, extending the market dominance of traditional energy sources where Exxon is well-positioned.
Read Also: <a href="https://www.benzinga.com/24/11/41971559/disneys-q4-boosted-by-streaming-gains-strong-box-office-and-solid-parks-performance">Disney Q4 Earnings: Revenue And Profit Beat, Best Film Studio Performance, 3-Year Outlook And More</a>
What Else: Trump's protectionist trade policies, particularly his advocacy for tariffs on foreign imports, could also play a role in shaping Exxon's strategy. 
While higher tariffs could increase costs for some imported materials used in refining and exploration, the overarching goal to strengthen domestic energy independence aligns with Exxon's core U.S. operations. 
Furthermore, Trump's inclination to ease sanctions on certain countries, such as Russia, could create new avenues for Exxon to partner in international projects, a potential growth area constrained by recent sanctions.
While uncertainties remain in the global oil market, Trump's commitment to bolstering fossil fuel production and easing regulatory constraints provides an optimistic outlook for Exxon's growth trajectory, making the stock an appealing choice for energy investors post-election.
Read Also: <a href="https://www.benzinga.com/economics/macro-economic-events/24/11/41971830/producer-inflation-rises-more-than-expected-in-october-should-traders-rethink-interest-rate-cut-path">Producer Inflation Rises More Than Expected In October: Should Traders Rethink Interest Rate Cut Path?</a>
<h2 class="wp-block-heading">How To Buy XOM Stock</h2>
By now you're likely curious about how to participate in the market for Exxon Mobil &#8211; be it to purchase shares, or even attempt to bet against the company.
Buying shares is typically done through a brokerage account. You can find a list of <a href="https://www.benzinga.com/money/best-stock-trading-platforms">possible trading platforms here.</a> Many will allow you to buy ‘fractional shares,' which allows you to own portions of stock without buying an entire share. For example, some stock, like Berkshire Hathaway, can cost thousands of dollars to own just one share. However, if you only want to invest a fraction of that, brokerages will allow you to do so.
In the the case of Exxon Mobil, which is trading at $121.61 as of publishing time, $100 would buy you 0.82 shares of stock.
If you're looking to bet against a company, the process is more complex. You'll need access to an options trading platform, or a broker who will allow you to ‘go short' a share of stock by lending you the shares to sell. The process of shorting a <a href="https://www.benzinga.com/money/how-to-short-a-stock">stock can be found at this resource.</a> Otherwise, if your broker allows you to trade options, you can either buy a put option, or sell a call option at a strike price above where shares are currently trading &#8211; either way it allows you to profit off of the share price decline.
According to data from&nbsp;<a href="https://benzinga.grsm.io/register174">Benzinga Pro</a>, XOM has a 52-week high of $126.34 and a 52-week low of $95.77.

What's Going On With Exxon Mobil (XOM) Stock?

Goldman Sachs analyst Mark Delaney maintains Luminar Technologies (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LAZR#NASDAQ">LAZR</a>) with a Sell and lowers the price target from $0.75 to $0.5.

LAZR

Goldman Sachs Maintains Sell on Luminar Technologies, Lowers Price Target to $0.5

Salesforce Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CRM#NYSE">CRM</a>) is aggressively embracing AI in enterprise software. CEO Marc Benioff is positioning the company&#8217;s AI agents as the industry&#8217;s next significant evolution.
The company plans to deploy software bots that can handle various tasks autonomously, aiming to streamline operations and reduce the workload for human employees.
Also Read: <a target="_blank" href="https://www.benzinga.com/top-stories/24/10/41428765/microsoft-salesforce-battle-heats-up-as-ai-agent-technology-takes-center-stage" rel="noreferrer noopener">Microsoft, Salesforce Battle Heats Up As AI Agent Technology Takes Center Stage</a>
During a recent episode of the Equity podcast, Benioff shared his vision, underscoring how this shift could reshape enterprise software as we know it.
Benioff emphasized the potential of these AI agents to revolutionize productivity by extending workforce capabilities without limitations, TechCrunch <a target="_blank" href="https://techcrunch.com/podcast/marc-benioff-says-its-crazy-talk-that-ai-will-hurt-salesforce-wants-a-billion-ai-agents-in-a-year/" rel="noreferrer noopener">reports</a>.
The Salesforce chief noted that hundreds of companies already leverage <a target="_blank" href="https://www.benzinga.com/markets/equities/24/10/41607435/salesforce-launches-agentforce-redefining-ai-in-business-with-autonomous-solutions" rel="noreferrer noopener">the Agentforce platform</a>, an AI-driven tool enabling autonomous task execution across business functions.
He set an ambitious target of deploying a billion AI agents within a year, showcasing this technology&#8217;s scalability and market demand.
Benioff shared a personal example from a recent visit to a Disney park, using the company&#8217;s virtual tour guide feature. The AI agent analyzed historical ride preferences and current park traffic, suggesting customized itineraries.
This personalized approach demonstrated how AI can enhance user experiences across different sectors, including entertainment, retail, and healthcare.
While Salesforce continues to develop its Agentforce platform, Benioff criticized Microsoft Corp&#8217;s (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MSFT#NASDAQ">MSFT</a>) AI offerings and expressed skepticism about Microsoft&#8217;s Copilot agents. He cited user complaints and research indicating security and functionality issues with Microsoft&#8217;s solutions.
Despite the rise of new AI-focused startups, Benioff remains confident in Salesforce&#8217;s position.
Benioff emphasized that Salesforce&#8217;s secure data infrastructure sets it apart, enabling more reliable AI-driven insights and services.
As part of its growth strategy, Salesforce uses its own AI agents internally across various departments, including customer service and sales.
<figure class="wp-block-image size-full"><img loading="lazy" decoding="async" width="750" height="650" src="https://editorial-assets.benzinga.com/wp-content/uploads/2024/11/14093208/newplot-8.png" alt="" class="wp-image-648092" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2024/11/14093208/newplot-8.png 750w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/11/14093208/newplot-8-300x260.png 300w" sizes="(max-width: 750px) 100vw, 750px" /></figure>
Northland Capital Partners said Salesforce&#8217;s AgentForce platform <a target="_blank" href="https://www.benzinga.com/top-stories/24/10/41145130/salesforces-genai-platform-agentforce-on-par-with-microsoft-analyst" rel="noreferrer noopener">is &#8220;on par&#8221; with</a> Microsoft.
Jim Cramer, host of CNBC&#8217;s &#8220;Mad Money,&#8221; praised Salesforce for its <a target="_blank" href="https://www.benzinga.com/markets/equities/24/11/41890694/jim-cramer-says-salesforce-agentforce-is-the-best-use-of-ai-he-has-seen-makes-sense-that-the-stock-has-gone-up-so-much" rel="noreferrer noopener">innovative AI product</a>, Agentforce, crediting the tool for driving the recent surge in the company&#8217;s stock.
Cramer shared his views on X, describing Agentforce as &#8220;pretty revolutionary.&#8221; He pointed out that the stock&#8217;s upward movement aligns with the impact of this cutting-edge AI solution and highlighted it as the most effective AI use case he has seen, validating the stock&#8217;s rally.
Salesforce&nbsp;stock surged over 33% year-to-date. Investors can gain exposure to the stock through SPDR Select Sector Fund &#8211; Technology (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XLK#NYSE">XLK</a>) and Vanguard Total Stock Market ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/VTI#NYSE">VTI</a>).
Price Action: CRM stock is down 2.18% at $334.28 at the last check on Thursday.
Also Read:
<ul>
<li><a href="https://www.benzinga.com/24/11/41971559/disneys-q4-boosted-by-streaming-gains-strong-box-office-and-solid-parks-performance" target="_blank" rel="noreferrer noopener">Disney Q4 Earnings: Revenue And Profit Beat, Best Film Studio Performance, 3-Year Outlook And More</a></li>
</ul>
Photo by NYCStock via Shutterstock

Management

Tech

Media

MSFT

Salesforce CEO Marc Benioff Bets Big on Billion Bots

Canaccord Genuity analyst Sumant Kulkarni maintains Zevra Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ZVRA#NASDAQ">ZVRA</a>) with a Buy and lowers the price target from $25 to $23.

ZVRA

Canaccord Genuity Maintains Buy on Zevra Therapeutics, Lowers Price Target to $23

RBC Capital analyst Michael Harvey reiterates Peyto Exploration &amp; Dev (TSX:<a class="ticker" href="https://www.benzinga.com/stock/PEY#TSX">PEY</a>) with a Sector Perform and maintains C$17 price target.

TSX:PEY

RBC Capital Reiterates Sector Perform on Peyto Exploration & Dev, Maintains C$17 Price Target

Goldman Sachs analyst Ryan Nash maintains loanDepot (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LDI#NYSE">LDI</a>) with a Sell and raises the price target from $1.7 to $2.7.

Goldman Sachs Maintains Sell on loanDepot, Raises Price Target to $2.7

On Thursday, Immutep Limited&nbsp;(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IMMP#NASDAQ">IMMP</a>) released data from the INSIGHT-003 Phase 1 trial of eftilagimod alpha (efti) in combination with Merck &amp; Co Inc&#8217;s (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MRK#NYSE">MRK</a>) Keytruda (pembrolizumab) and chemotherapy for first-line treatment of metastatic non-squamous non-small cell lung <a target="_blank" href="https://www.benzinga.com/pressreleases/24/11/g41970785/immuteps-efti-shows-excellent-survival-data-from-insight-003-trial-in-non-small-cell-lung-cancer" rel="noreferrer noopener">cancer (1L NSCLC) patients</a>.
The survival data as of data cutoff of Oct. 15 from the triple combination therapy in patients irrespective of PD-L1 expression with a minimum followup of 22 months (N=21) shows:
<ul>
<li>Median Overall Survival (OS) of 32.9 months.</li>
<li>Median Progression-Free Survival (PFS) of 12.7 months.</li>
<li>24-month Overall Survival (OS) of 81.0%.</li>
</ul>
Also Read: <a target="_blank" href="https://www.benzinga.com/general/biotech/24/07/39747049/australia-based-cancer-focused-immuteps-lead-cancer-drug-shows-meaningful-response-in-untreated-h" rel="noreferrer noopener">Australia Based Cancer Focused Immutep&#8217;s Lead Cancer Drug Shows &#8216;Meaningful Response&#8217; In Untreated Head &amp; Neck Cancer, Stock Soars</a>
The company compares the data with the 22.0-month median OS, 9.0-month median PFS, and 24-month OS rate of 45.5% from a registrational trial of anti-PD-1 and doublet chemotherapy in non-squamous 1L NSCLC regardless of PD-L1 expression.
Marc Voigt, CEO of Immutep, said, &#8220;The overall survival and progression-free survival data from this mature cohort of patients in INSIGHT-003 with nearly a 2-year minimum followup exceeds our expectations.&#8221;
Data from all evaluable patients to date (N=40) demonstrates significant improvement in Overall Response Rate (ORR) across all levels of PD-L1 expression compared to historical control:
<ul>
<li>75.0% ORR versus 62.1% ORR in patients with high PD-L1 expression.</li>
<li>58.8% ORR versus 49.2% ORR in patients with low PD-L1 expression.</li>
<li>47.4% ORR versus 32.3% ORR in patients with negative PD-L1.</li>
<li>In this all-comer PD-L1 trial, the 55.0% ORR and 87.5% Disease Control Rate (DCR) are from the following breakdown of patients by PD-L1 expression: high PD-L1 expression (N=4), low PD-L1 expression (N=17), and negative PD-L1 (N=19).</li>
<li>Compared to the general 1L NSCLC patient population, each of these PD-L1 levels represents roughly one-third, INSIGHT-003 is biased towards low and negative PD-L1 patients who are typically less responsive to anti-PD-1 therapy.</li>
<li>In these patients with low and negative PD-L1 expression (36 of 40 patients), the triple combination achieved a 52.8% ORR and 86.1% DCR.</li>
</ul>
INSIGHT-003, a multi-centre study led by the Frankfurt Institute of Clinical Cancer Research IKF, is nearing completion of patient enrolment.
Additional data updates from this trial are expected in 2025 and beyond.
Price Action: IMMP stock is up 9.6% at $2.05 at last check Thursday.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/general/biotech/24/11/41970133/exclusive-adial-pharmaceuticals-reveals-topline-results-from-pharmacokinetics-study-of-ad04-for-alcohol-use-disorder" target="_blank" rel="noreferrer noopener">EXCLUSIVE: Adial Pharmaceuticals Reveals Topline Results From Pharmacokinetics Study Of AD04 For Alcohol Use Disorder</a></li>
</ul>
Photo: Shutterstock

Biotech

Health Care

General

IMMP

Immutep's Lead Cancer Drug Shows Promising 2-Year Survival Data In Lung Cancer Trial

Whales with a lot of money to spend have taken a noticeably bearish stance on Shopify.
Looking at options history for Shopify (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SHOP#NYSE">SHOP</a>) we detected 42 trades.
If we consider the specifics of each trade, it is accurate to state that 26% of the investors opened trades with bullish expectations and 52% with bearish.
From the overall spotted trades, 9 are puts, for a total amount of $691,916 and 33, calls, for a total amount of $5,852,437.
<h3>Predicted Price Range</h3>
Taking into account the Volume and Open Interest on these contracts, it appears that whales have been targeting a price range from $40.0 to $120.0 for Shopify over the last 3 months. 
<h3>Insights into Volume &amp; Open Interest</h3>
Looking at the volume and open interest is a powerful move while trading options. This data can help you track the liquidity and interest for Shopify's options for a given strike price. Below, we can observe the evolution of the volume and open interest of calls and puts, respectively, for all of Shopify's whale trades within a strike price range from $40.0 to $120.0 in the last 30 days. 
<h3>Shopify 30-Day Option Volume &amp; Interest Snapshot</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1731600949_0.png" alt="Options Call Chart" />
<h3>Noteworthy Options Activity:</h3>

<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Ask</th>
<th>Bid</th>
<th>Price</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th>Open Interest</th>
<th>Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>SHOP</td>
<td>CALL</td>
<td>SWEEP</td>
<td>NEUTRAL</td>
<td>06/20/25</td>
<td>$29.4</td>
<td>$28.8</td>
<td>$29.04</td>
<td>$90.00</td>
<td>$1.1M</td>
<td>4.3K</td>
<td>2.0K</td>
</tr>
<tr>
<td>SHOP</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>01/16/26</td>
<td>$22.7</td>
<td>$22.0</td>
<td>$22.7</td>
<td>$115.00</td>
<td>$1.1M</td>
<td>2.2K</td>
<td>1.8K</td>
</tr>
<tr>
<td>SHOP</td>
<td>CALL</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>01/16/26</td>
<td>$22.6</td>
<td>$22.4</td>
<td>$22.4</td>
<td>$115.00</td>
<td>$672.0K</td>
<td>2.2K</td>
<td>1.8K</td>
</tr>
<tr>
<td>SHOP</td>
<td>CALL</td>
<td>SWEEP</td>
<td>NEUTRAL</td>
<td>06/20/25</td>
<td>$15.9</td>
<td>$15.15</td>
<td>$15.54</td>
<td>$115.00</td>
<td>$634.6K</td>
<td>6.0K</td>
<td>2.0K</td>
</tr>
<tr>
<td>SHOP</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>06/20/25</td>
<td>$15.55</td>
<td>$15.15</td>
<td>$15.48</td>
<td>$115.00</td>
<td>$485.3K</td>
<td>6.0K</td>
<td>2.0K</td>
</tr>
</tbody>
</table>

<h3>About Shopify</h3>
Shopify offers an e-commerce platform primarily to small and medium-size businesses. The firm has two segments. The subscription solutions segment allows Shopify merchants to conduct e-commerce on a variety of platforms, including the company's website, physical stores, pop-up stores, kiosks, social networks (Facebook), and Amazon. The merchant solutions segment offers add-on products for the platform that facilitate e-commerce and include Shopify Payments, Shopify Shipping, and Shopify Capital.
In light of the recent options history for Shopify, it's now appropriate to focus on the company itself. We aim to explore its current performance.
<h3>Where Is Shopify Standing Right Now?</h3>
<ul>
<li>With a trading volume of 5,624,338, the price of SHOP is down by -4.56%, reaching $109.84.</li>
<li>Current RSI values indicate that the stock is may be overbought.</li>
<li>Next earnings report is scheduled for 89 days from now.</li>
</ul>
<h3>What Analysts Are Saying About Shopify</h3>
Over the past month, 5 industry analysts have shared their insights on this stock, proposing an average target price of $112.4.
Unusual Options Activity Detected: Smart Money on the Move
Benzinga Edge's Unusual Options board spots potential market movers before they happen. See what positions big money is taking on your favorite stocks. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=Be8be9arja3be22bz20&amp;utm_source=benzinga-insights">Click here for access</a>. 
&#x2A; Consistent in their evaluation, an analyst from Keybanc keeps a Overweight rating on Shopify with a target price of $130. 
&#x2A; Maintaining their stance, an analyst from Barclays continues to hold a Equal-Weight rating for Shopify, targeting a price of $93. 
&#x2A; Consistent in their evaluation, an analyst from Piper Sandler keeps a Neutral rating on Shopify with a target price of $94. 
&#x2A; Consistent in their evaluation, an analyst from Canaccord Genuity keeps a Buy rating on Shopify with a target price of $125. 
&#x2A; Consistent in their evaluation, an analyst from JMP Securities keeps a Market Outperform rating on Shopify with a target price of $120. 
Options trading presents higher risks and potential rewards. Astute traders manage these risks by continually educating themselves, adapting their strategies, monitoring multiple indicators, and keeping a close eye on market movements. Stay informed about the latest Shopify options trades with real-time alerts from <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a>.

Options

Markets

SHOP

Shopify Unusual Options Activity

Deep-pocketed investors have adopted a bullish approach towards Amgen (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMGN#NASDAQ">AMGN</a>), and it's something market players shouldn't ignore. Our tracking of public options records at Benzinga unveiled this significant move today. The identity of these investors remains unknown, but such a substantial move in AMGN usually suggests something big is about to happen.
We gleaned this information from our observations today when Benzinga's options scanner highlighted 8 extraordinary options activities for Amgen. This level of activity is out of the ordinary.
The general mood among these heavyweight investors is divided, with 50% leaning bullish and 25% bearish. Among these notable options, 4 are puts, totaling $137,540, and 4 are calls, amounting to $285,919.
<h3>Projected Price Targets</h3>
Based on the trading activity, it appears that the significant investors are aiming for a price territory stretching from $290.0 to $340.0 for Amgen over the recent three months. 
<h3>Insights into Volume &amp; Open Interest</h3>
Looking at the volume and open interest is an insightful way to conduct due diligence on a stock.
This data can help you track the liquidity and interest for Amgen's options for a given strike price.
Below, we can observe the evolution of the volume and open interest of calls and puts, respectively, for all of Amgen's whale activity within a strike price range from $290.0 to $340.0 in the last 30 days. 
<h3>Amgen Option Volume And Open Interest Over Last 30 Days</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1731600944_0.png" alt="Options Call Chart" />
<h3>Significant Options Trades Detected:</h3>

<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Ask</th>
<th>Bid</th>
<th>Price</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th>Open Interest</th>
<th align="right">Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>AMGN</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>01/15/27</td>
<td>$43.6</td>
<td>$43.55</td>
<td>$43.6</td>
<td>$300.00</td>
<td>$196.2K</td>
<td>25</td>
<td align="right">0</td>
</tr>
<tr>
<td>AMGN</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>01/17/25</td>
<td>$52.8</td>
<td>$51.5</td>
<td>$51.5</td>
<td>$340.00</td>
<td>$51.5K</td>
<td>190</td>
<td align="right">19</td>
</tr>
<tr>
<td>AMGN</td>
<td>CALL</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>12/20/24</td>
<td>$10.3</td>
<td>$9.2</td>
<td>$10.0</td>
<td>$310.00</td>
<td>$38.0K</td>
<td>1.8K</td>
<td align="right">62</td>
</tr>
<tr>
<td>AMGN</td>
<td>PUT</td>
<td>SWEEP</td>
<td>NEUTRAL</td>
<td>12/20/24</td>
<td>$15.65</td>
<td>$15.2</td>
<td>$15.45</td>
<td>$290.00</td>
<td>$33.9K</td>
<td>1.5K</td>
<td align="right">30</td>
</tr>
<tr>
<td>AMGN</td>
<td>CALL</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>12/06/24</td>
<td>$2.95</td>
<td>$2.08</td>
<td>$2.29</td>
<td>$340.00</td>
<td>$26.5K</td>
<td>112</td>
<td align="right">121</td>
</tr>
</tbody>
</table>

<h3>About Amgen</h3>
Amgen is a leader in biotechnology-based human therapeutics. Flagship drugs include red blood cell boosters Epogen and Aranesp, immune system boosters Neupogen and Neulasta, and Enbrel and Otezla for inflammatory diseases. Amgen introduced its first cancer therapeutic, Vectibix, in 2006 and markets bone-strengthening drug Prolia/Xgeva (approved 2010) and Evenity (2019). The acquisition of Onyx bolstered the firm's therapeutic oncology portfolio with Kyprolis. Recent launches include Repatha (cholesterol-lowering), Aimovig (migraine), Lumakras (lung cancer), and Tezspire (asthma). The 2023 Horizon acquisition brings several rare-disease drugs, including thyroid eye disease drug Tepezza. Amgen also has a growing biosimilar portfolio.
<h3>Amgen's Current Market Status</h3>
<ul>
<li>Currently trading with a volume of 856,173, the AMGN's price is down by -2.03%, now at $295.33. </li>
<li>RSI readings suggest the stock is currently may be oversold.</li>
<li>Anticipated earnings release is in 82 days.</li>
</ul>
<h3>What Analysts Are Saying About Amgen</h3>
Over the past month, 5 industry analysts have shared their insights on this stock, proposing an average target price of $360.8.
Turn $1000 into $1270 in just 20 days?
20-year pro options trader reveals his one-line chart technique that shows when to buy and sell. Copy his trades, which have had averaged a 27% profit every 20 days. <a href="https://www.benzinga.com/premium/ideas/options-moneyline-2/?t=Moop1arja3be22op14&amp;utm_source=benzinga-insights">Click here for access</a>. 
&#x2A; An analyst from Bernstein downgraded its action to Outperform with a price target of $380. 
&#x2A; Maintaining their stance, an analyst from Jefferies continues to hold a Buy rating for Amgen, targeting a price of $380. 
&#x2A; In a cautious move, an analyst from Citigroup downgraded its rating to Neutral, setting a price target of $335. 
&#x2A; An analyst from TD Cowen persists with their Buy rating on Amgen, maintaining a target price of $383. 
&#x2A; Maintaining their stance, an analyst from UBS continues to hold a Neutral rating for Amgen, targeting a price of $326. 
Options are a riskier asset compared to just trading the stock, but they have higher profit potential. Serious options traders manage this risk by educating themselves daily, scaling in and out of trades, following more than one indicator, and following the markets closely.
If you want to stay updated on the latest options trades for Amgen, <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a> gives you real-time options trades alerts.

AMGN

Amgen's Options Frenzy: What You Need to Know

Deep-pocketed investors have adopted a bullish approach towards Walmart (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WMT#NYSE">WMT</a>), and it's something market players shouldn't ignore. Our tracking of public options records at Benzinga unveiled this significant move today. The identity of these investors remains unknown, but such a substantial move in WMT usually suggests something big is about to happen.
We gleaned this information from our observations today when Benzinga's options scanner highlighted 23 extraordinary options activities for Walmart. This level of activity is out of the ordinary.
The general mood among these heavyweight investors is divided, with 60% leaning bullish and 26% bearish. Among these notable options, 3 are puts, totaling $153,872, and 20 are calls, amounting to $2,986,061.
<h3>What's The Price Target?</h3>
Based on the trading activity, it appears that the significant investors are aiming for a price territory stretching from $60.0 to $86.67 for Walmart over the recent three months. 
<h3>Volume &amp; Open Interest Development</h3>
In today's trading context, the average open interest for options of Walmart stands at 10636.8, with a total volume reaching 97,378.00. The accompanying chart delineates the progression of both call and put option volume and open interest for high-value trades in Walmart, situated within the strike price corridor from $60.0 to $86.67, throughout the last 30 days.
<h3>Walmart Option Volume And Open Interest Over Last 30 Days</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1731600938_0.png" alt="Options Call Chart" />
<h3>Biggest Options Spotted:</h3>

<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Ask</th>
<th>Bid</th>
<th>Price</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th>Open Interest</th>
<th>Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>WMT</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>12/20/24</td>
<td>$2.57</td>
<td>$2.54</td>
<td>$2.57</td>
<td>$86.67</td>
<td>$476.0K</td>
<td>10.0K</td>
<td>3.6K</td>
</tr>
<tr>
<td>WMT</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>12/20/24</td>
<td>$2.59</td>
<td>$2.55</td>
<td>$2.58</td>
<td>$86.67</td>
<td>$464.9K</td>
<td>10.0K</td>
<td>6.6K</td>
</tr>
<tr>
<td>WMT</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>12/20/24</td>
<td>$2.57</td>
<td>$2.55</td>
<td>$2.58</td>
<td>$86.67</td>
<td>$398.6K</td>
<td>10.0K</td>
<td>1.6K</td>
</tr>
<tr>
<td>WMT</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>12/20/24</td>
<td>$2.58</td>
<td>$2.55</td>
<td>$2.58</td>
<td>$86.67</td>
<td>$231.9K</td>
<td>10.0K</td>
<td>4.6K</td>
</tr>
<tr>
<td>WMT</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>12/20/24</td>
<td>$2.59</td>
<td>$2.55</td>
<td>$2.58</td>
<td>$86.67</td>
<td>$206.6K</td>
<td>10.0K</td>
<td>7.5K</td>
</tr>
</tbody>
</table>

<h3>About Walmart</h3>
Walmart serves as the preeminent retailer in the United States, with its strategy predicated on superior operating efficiency and offering the lowest priced goods to consumers to drive robust store traffic and product turnover. Walmart augmented its low-price business strategy by offering a convenient one-stop shopping destination with the opening of its first supercenter in 1988.Today, Walmart operates over 4,600 stores in the United States (5,200 including Sam's Club) and over 10,000 stores globally. Walmart generated over $440 billion in domestic namesake sales in fiscal 2024, with Sam's Club contributing another $86 billion to the company's top line. Internationally, Walmart generated $115 billion in sales. The retailer serves around 240 million customers globally each week.
<h3>Walmart's Current Market Status</h3>
<ul>
<li>With a trading volume of 2,967,114, the price of WMT is up by 0.04%, reaching $85.53.</li>
<li>Current RSI values indicate that the stock is is currently neutral between overbought and oversold.</li>
<li>Next earnings report is scheduled for 5 days from now.</li>
</ul>
<h3>What Analysts Are Saying About Walmart</h3>
A total of 5 professional analysts have given their take on this stock in the last 30 days, setting an average price target of $89.2.
Turn $1000 into $1270 in just 20 days?
20-year pro options trader reveals his one-line chart technique that shows when to buy and sell. Copy his trades, which have had averaged a 27% profit every 20 days. <a href="https://www.benzinga.com/premium/ideas/options-moneyline-2/?t=Moop1arja3be22op14&amp;utm_source=benzinga-insights">Click here for access</a>. 
&#x2A; Maintaining their stance, an analyst from Morgan Stanley continues to hold a Overweight rating for Walmart, targeting a price of $89. 
&#x2A; Consistent in their evaluation, an analyst from Keybanc keeps a Overweight rating on Walmart with a target price of $87. 
&#x2A; Maintaining their stance, an analyst from Telsey Advisory Group continues to hold a Outperform rating for Walmart, targeting a price of $92. 
&#x2A; An analyst from Wells Fargo has decided to maintain their Overweight rating on Walmart, which currently sits at a price target of $90. 
&#x2A; An analyst from Keybanc persists with their Overweight rating on Walmart, maintaining a target price of $88. 
Options trading presents higher risks and potential rewards. Astute traders manage these risks by continually educating themselves, adapting their strategies, monitoring multiple indicators, and keeping a close eye on market movements. Stay informed about the latest Walmart options trades with real-time alerts from <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a>.

What the Options Market Tells Us About Walmart

Nvidia&#8217;s CEO, Jensen Huang, shared something surprising during a Fireside Chat at the CASPA 2023 Annual <a href="https://www.youtube.com/watch?v=z8cAXOys3bI">Conference</a>. He said that Nvidia (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVDA#NASDAQ">NVDA</a>) has no long-term plan. This might sound strange coming from the leader of a Big Tech company, but Huang had a simple reason: focus on the present.
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true">Why Jensen Huang doesn't wear a watch: <a href="https://t.co/i1RW625mdI">pic.twitter.com/i1RW625mdI</a>
&mdash; Arjun Khemani (@arjunkhemani) <a href="https://twitter.com/arjunkhemani/status/1855613536187142367?ref_src=twsrc%5Etfw">November 10, 2024</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
Don't Miss:
<ul>
<li>The global games market is projected to generate $272B by the end of the year —<a href="https://www.benzinga.com/money/gameflip"> for $0.55/share, this VC-backed startup with a 7M+ userbase gives investors easy access to this asset market.</a></li>
<li>With over 7.8K investors including Meta, Google, And Amazon Execs — this AI Startup's valuation has skyrocketed from $5 million to $85 million in just three years. <a href="https://www.benzinga.com/money/rad-ai">Be an early investor with just $1,000 for only $0.50/share today before the offer closes in 2 weeks.</a></li>
</ul>
Huang said that both in his personal life and in leading Nvidia, he doesn't believe in stressing over long-term plans. In fact, he doesn't even wear a watch – on purpose. This choice reflects his belief that the most important time is right now. This mindset, he says, is what <a href="https://www.benzinga.com/markets/equities/24/05/38911606/nvidias-2-trillion-success-story-how-an-act-of-kindness-from-a-top-sega-executive-saved-the-jens">has made Nvidia successful</a>, from graphics cards to artificial intelligence. Instead of worrying about the future, Nvidia works on solving today's problems in the best way possible.
This way of thinking has helped Nvidia become important in gaming, AI, robotics <a href="https://www.benzinga.com/markets/equities/24/09/40939729/energy-meets-ai-schlumberger-teams-up-with-nvidia-to-supercharge-industry-efficiency">and even climate modeling</a>. Huang explained that planning too far ahead can make you miss what's happening right before you. For Nvidia, it means staying flexible and being ready to jump on opportunities as they come – something that has worked well since they've adapted to meet the needs of fields like digital biology and AI.
Trending: Deloitte's fastest-growing software company partners with Amazon, Walmart &amp; Target –<a href="https://www.benzinga.com/money/mode-mobile-2"> You can still get 4,000 of its pre-IPO shares for just $1,000</a>
&#8220;We don't have a long-term strategy,&#8221; Huang <a href="https://x.com/arjunkhemani/status/1855613536187142367">said</a>. &#8220;Our definition of a long-term plan is: what are we doing today?&#8221; By focusing on the present, Nvidia has led in areas like AI and accelerated computing that traditional computing hasn't kept up with.
Not having a strict plan doesn't mean Nvidia has no direction. Instead, it means they are always learning, changing and adjusting based on what's happening right before them. Huang said this approach is why <a href="https://www.benzinga.com/startups/24/09/40692021/nvidia-ceo-jensen-huang-will-push-employees-to-their-limits-but-is-reluctant-to-let-them-go-ill-tort">Nvidia keeps pushing limits</a>, especially with technologies like CUDA, which many doubted initially but <a href="https://www.benzinga.com/news/24/09/40692210/nvidia-maintains-ai-chip-dominance-as-huawei-struggles-to-compete-report">ended up changing computing</a>.
See Also: Warren Buffett once said, "If you don't find a way to make money while you sleep, you will work until you die." <a href="https://www.benzinga.com/money/connect-invest-real-estate-notes">These high-yield real estate notes that pay 7.5% &#8211; 9% make earning passive income easier than ever.</a>
Huang&#8217;s advice for young people or anyone who aspires to achieve was straightforward – concentrate on your current tasks. He thinks every day should be spent doing the finest work possible without worrying too much about the future. This doesn't mean you have no goals; instead, it means letting the present guide you. It's a refreshing way to look at life and work in a world where everyone seems to be rushing toward future goals without focusing on today.
Read Next:
<ul>
<li>‘Scrolling to UBI': Deloitte's #1 fastest-growing software company allows users to earn money on their phones –<a href="https://www.benzinga.com/money/mode-mobile-2"> invest today with $1,000 for just $0.25/share</a></li>
<li>This Adobe-backed AI marketing startup went from a $5 to $85 million valuation working with brands like L'Oréal, Hasbro, and Sweetgreen in just three years –<a href="https://www.benzinga.com/money/rad-ai"> here's how there's a limited time opportunity to invest at $1,000 for only $0.50/share before closing date.</a></li>
</ul>

Startups

NVDA

Jensen Huang Reveals 'Nvidia Doesn't Have A Long-Term Strategy' Or Plan. The Reason Behind It Is The Same For Why He Doesn't Wear A Watch

Canaccord Genuity analyst David Hynes maintains Zeta Global Holdings (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ZETA#NYSE">ZETA</a>) with a Buy and lowers the price target from $42 to $24.

ZETA

Canaccord Genuity Maintains Buy on Zeta Global Holdings, Lowers Price Target to $24

Goldman Sachs analyst Mark Delaney maintains Innoviz Technologies (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/INVZ#NASDAQ">INVZ</a>) with a Neutral and lowers the price target from $1 to $0.75.

INVZ

Goldman Sachs Maintains Neutral on Innoviz Technologies, Lowers Price Target to $0.75

Canaccord Genuity analyst Sumant Kulkarni maintains Voyager Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VYGR#NASDAQ">VYGR</a>) with a Buy and maintains $14 price target.

VYGR

Canaccord Genuity Maintains Buy on Voyager Therapeutics, Maintains $14 Price Target

Goldman Sachs analyst Eric Sheridan maintains Groupon (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GRPN#NASDAQ">GRPN</a>) with a Sell and lowers the price target from $11 to $8.

GRPN

Goldman Sachs Maintains Sell on Groupon, Lowers Price Target to $8

Canaccord Genuity analyst Maria Ripps maintains Spotify Technology (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SPOT#NYSE">SPOT</a>) with a Buy and raises the price target from $475 to $525.

SPOT

Canaccord Genuity Maintains Buy on Spotify Technology, Raises Price Target to $525

RBC Capital analyst Rishi Jaluria maintained a Hold rating on Smartsheet (SMAR – Research Report) yesterday and set a price target of $56.50. The c...

RBC Capital Sticks to Its Hold Rating for Smartsheet (SMAR)

Analysts have been eager to weigh in on the Technology sector with new ratings on ServiceNow (NOW – Research Report), Maxlinear (MXL – Research Rep...

Analysts Conflicted on These Technology Names: ServiceNow (NOW), Maxlinear (MXL) and Smartsheet (SMAR)

Smartsheet gains after deal background shows another party considering cash/stock offer

The SaaS sector offers a blend of innovation and resilience, making it an intelligent investment as businesses turn to cloud solutions. Given this trend, it could be wise to invest in high-growth SaaS stocks, DocuSign (DOCU), Twilio (TWLO), and Smartsheet (SMAR). Keep reading… As more companies rely on cloud solutions and AI-driven tools to enhance operations and boost efficiency, the SaaS (Software-as-a-Service) industry is expected to develop significantly. Thus, investors might want to scoop up shares of SaaS stocks, such as DocuSign, Inc. (<a href="https://stocknews.com/stock/DOCU/">DOCU</a>), Twilio Inc. (<a href="https://stocknews.com/stock/TWLO/">TWLO</a>), and Smartsheet Inc. (<a href="https://stocknews.com/stock/SMAR/">SMAR</a>), given their growth potential.
As the SaaS industry evolves, growth potential lies not only in core functionalities but also in strategic partnerships and expanding service portfolios. Modern technological advances have also contributed to the growth of personalized products, and that has <a href="https://medium.com/@marketing.cyperstudio/evolution-of-the-saas-industry-the-rise-of-customized-saas-products-fe2a77eb9964">enabled SaaS providers to provide highly customized systems</a> that can adapt and learn from user behavior thanks to machine learning, artificial intelligence, and advanced analytics.
According to <a href="https://www.statista.com/outlook/tmo/public-cloud/software-as-a-service/worldwide">Statista</a>, the global SaaS market is anticipated to reach $793.10 billion by 2029, exhibiting a CAGR of 19.3%. It is estimated that by 2025, <a href="http://pages.bettercloud.com/rs/719-KZY-706/images/2020_StateofSaaSOpsReport.pdf">85% of business apps will be SaaS-based</a>.  Gartner predicts that by 2026, <a href="https://www.gartner.com/en/newsroom/press-releases/2021-08-02-gartner-says-four-trends-are-shaping-the-future-of-public-cloud">public cloud spending is projected to exceed 45%</a> of all enterprise IT spending.
Moreover, SaaS companies often generate recurring revenue through subscription models, which ensures cash flow stability and makes them resilient during economic downturns. This makes them a compelling addition to portfolios with long-term goals.
Now, let's take a closer look at the fundamentals of the <a href="https://stocknews.com/category/software-saas/">Software - SAAS</a> stocks mentioned above, beginning with the third choice.
Stock #3: Twilio Inc. (<a href="https://stocknews.com/stock/TWLO/">TWLO</a>)
TWLO provides a customer engagement platform comprising international communications application programming interfaces. It operates through two segments: Twilio Communications and Twilio Data &amp; Applications.
On October 1, TWLO and OpenAI collaborated to integrate OpenAI's Realtime API into its platform. This integration will enable TWLO to build conversational AI applications and agents, which will bring customers more natural interactions to the platform.
On September 9, TWLO announced expanded accessibility of Rich Communication Services (RCS) messaging via its Programmable Messaging and Verify APIs to enhance branded and verified messaging and build customer trust in its source.
In the fiscal second quarter that ended on June 30, 2024, TWLO's revenue increased 4.3% year-over-year to $1.08 billion with a non-GAAP gross margin of 53.3% (up 110 bps year-over-year). The company reported non-GAAP income from operations of $175.32 million, indicating a 45.9% growth from the prior-year quarter.
TWLO's non-GAAP net income came in at $150.12 million, up 48.9% year-over-year, while its non-GAAP net income per share grew 61.1% from the year-ago value to $0.87. Also, its <a href="https://www.investopedia.com/terms/f/freecashflow.asp">free cash flow</a> increased 174.7% year-over-year to $197.58 million.
According to the financial guidance for fiscal year 2024, the company's non-GAAP income from operations is projected to be between $650 million and $675 million, with organic revenue growth anticipated to range from 6%-7%.
The consensus revenue estimate of $1.09 billion for the fiscal third quarter (ended September 2024) represents a 5.8% increase year-over-year. The consensus EPS estimate of $0.86 for the same quarter indicates a 47.6% improvement year-over-year. The company has an impressive surprise history; it surpassed the consensus revenue and EPS estimates in each of the trailing four quarters.
Moreover, TWLO's revenue has grown at CAGRs of 23.4% and 36.9% over the past three and five years, respectively. In addition, its total assets increased at 15.5% CAGR over the past five years.
The stock has surged 34.5% over the past year and 17.6% over the past three months to close the last trading session at $70.60.
TWLO's <a href="https://stocknews.com/powr-ratings/">POWR Ratings</a> reflect this robust outlook. The stock has an overall rating of B, which equates to Buy in our proprietary rating system. The POWR Ratings are calculated by considering 118 different factors, with each factor weighted to an optimal degree.
TWLO has an A grade for Growth and a B for Value and Sentiment. It is ranked #9 out of 18 stocks in the A-rated <a href="https://stocknews.com/category/software-saas/">Software - SAAS</a> industry. <a href="https://stocknews.com/stock/TWLO/">Click here</a> to see the additional ratings for TWLO (Momentum, Stability, and Quality).
Stock #2: Smartsheet Inc. (<a href="https://stocknews.com/stock/SMAR/">SMAR</a>)
SMAR provides a work management platform for organizations, allowing them to plan, capture, manage, automate, and report on work at scale. The company's platform enables teams of all sizes to manage custom processes, programs, and portfolios that fit, and it delivers its cloud-based software platform globally through a subscription model.
On October 8, SMAR announced its strategic collaboration with AWS to launch a new connector for Amazon Q Business that synchronizes data and provides insights to the customers. This new connector will allow the generative AI-powered assistant to answer customers' queries through a unified search experience.
SMAR's total revenue for the second quarter (ended July 31, 2024) increased 17.3% year-over-year to $276.41 million. Its non-GAAP operating income grew 135.7% from the prior year's quarter to $45.29 million.
The company's non-GAAP net income amounted to $61.64 million and $0.44 per share, reflecting increases of 180% and 175% year-over-year, respectively. In addition, SMAR's free cash flow rose 25.6% from the year-ago value to $57.15 million.
As per the fiscal year 2025 financial outlook, SMAR forecasts total revenue to range between $1.116 billion and $1.121 billion. The company also expects non-GAAP operating income to be between $177 million and $182 million and a free cash flow of $240 million. It also expects non-GAAP net income per share to be between $1.36 and $1.39.
Street expects SMAR's revenue for the fiscal third quarter (ending October 2024) to increase 15.4% year-over-year to $283.87 million. Its EPS for the same period is expected to register a 90.1% growth from the prior year, settling at $0.30. In addition, it surpassed the consensus revenue and EPS in each of the trailing four quarters, which is excellent.
Over the past three and five years, SMAR's revenue income grew at CAGRs of 31.6% and 36.5%, respectively, while its levered FCF grew at 47.3% CAGR over the past five years.
Over the past six months, the stock has gained 46%, closing the last trading session at $55.89.
It's no surprise that SMAR has an overall rating of B, equating to a Buy in our POWR Ratings system. It has an A grade for Growth and a B for Sentiment and Quality. Out of 18 stocks in the same A-rated industry, SMAR is ranked #6.
Beyond what is stated above, we've also rated SMAR for Value, Momentum, and Stability. Get all SMAR ratings <a href="https://stocknews.com/stock/SMAR/">here</a>.
Stock #1: DocuSign, Inc. (<a href="https://stocknews.com/stock/DOCU/">DOCU</a>)
DOCU provides cloud-based electronic signature solutions that enable sending and signing agreements, allowing organizations to do business faster with less risk and at a lower cost. It also offers contract lifecycle management software that automates workflows.
On June 4, DOCU announced the launch of a new connector for SAP Ariba solutions that will help automate workflows between DOCU's CLM and SAP Ariba, streamlining the source-to-pay process. This launch should enhance DOCU's market position and firmly establish the company as a leader.
On May 31, DOCU completed its acquisition of Lexion, a leading AI-powered agreement management company. This acquisition will strengthen DOCU's Intelligent Agreement Management (IAM) capabilities, bringing more insights, analysis, and automation to its customers.
For the second quarter of 2025, which ended on July 31, DOCU's total revenues increased 7% year-over-year to $736.03 million. Its non-GAAP income from operations stood at $237.16 million, indicating a 39.6% growth from the prior-year quarter.
DOCU's non-GAAP net income rose 34.3% from the year-ago value to $200.99 million, while its non-GAAP net income per share stood at $0.97, up 34.7% year-over-year. Also, the company's non-GAAP free cash flow grew by 7.8% from the year-ago value to $197.93 million.
Per the outlook for fiscal year 2025, DOCU expects its total revenue to be between $2.94 billion and $2.95 billion. It forecasts subscription revenue to range from $2.86 billion to $2.88 billion, with billings between $2.99 and $3.03 billion. Additionally, DOCU expects its non-GAAP operating margin to fall in the range of 29% to 29.5%.
Analysts expect DOCU's revenue for the third quarter ending October 31, 2024, to increase 6.4% year-over-year to $745.32 million, while its EPS for the same period is expected to grow 10.6% from the prior-year quarter to $0.87. The company surpassed consensus revenue and EPS estimates in each of the trailing four quarters, which is impressive.
DOCU's revenue has grown at CAGRs of 16.8% and 28.1% over the past three and five years, respectively. Likewise, the company's total assets have increased at a CAGR of 16.8% over the past three years.
DOCU shares have surged 76.1% over the past year and 25.8% over the past three months to close the last trading session at $70.56.
DOCU's bright prospects are reflected in its POWR Ratings. The stock has an overall rating of A, which translates to a Strong Buy in our proprietary rating system.
It also has an A grade for Quality and a B for Growth and Value. Within the A-rated Software - SAAS industry, it is ranked #2. <a href="https://stocknews.com/stock/DOCU/">Click here</a> to see DOCU's ratings for Momentum, Stability, and Sentiment.
What To Do Next?
43 year investment veteran, Steve Reitmeister, has just released his 2024 market outlook along with trading plan and top 11 picks for the year ahead.
<a href="https://report.stocknews.com/sign-up/stock-market-outlook-2024/?formplacement=artbotad_smo24_rep">2024 Stock Market Outlook &gt;</a>

<hr />
DOCU shares were trading at $71.34 per share on Thursday afternoon, up $0.78 (+1.11%). Year-to-date, DOCU has gained 20.00%, versus a 22.96% rise in the benchmark S&amp;P 500 index during the same period.
<hr><div style="clear:both;"></div> <h2>About the Author: ShreyaRathi</h2> <img src='https:/wp-content/uploads/2024/10/0.jpeg' style="float:left; padding:5px;width:125px;"><a href="https://stocknews.com/authors/?author=shreya-rathi">More...</a>The post <a href=https://stocknews.com/news/docu-twlo-smar-3-high-growth-saas-stocks-to-buy-before-the-next-boom/>3 High-Growth SaaS Stocks to Buy Before the Next Boom</a> appeared first on <a href=https://stocknews.com/>StockNews.com</a>

3 High-Growth SaaS Stocks to Buy Before the Next Boom

M&A deals roundup: Merck, Seadrill, Kraft Heinz, Spirit Airlines and more

Smartsheet (SMAR – Research Report) received a Hold rating and price target from Guggenheim analyst John Difucci yesterday. The company's shares cl...

Smartsheet (SMAR) was downgraded to a Hold Rating at Guggenheim

Guggenheim downgraded Smartsheet (SMAR) to Neutral from Buy without a price target citing the expiration of the "go-shop" period in the proposed ac...

Smartsheet downgraded to Neutral from Buy at Guggenheim

The most talked about and market moving research calls around Wall Street are now in one place. Here are today's research calls that investors need...

Comments

Smartsheet

매도 수량

Smartsheet (NYSE:SMAR) 주식, 공매도 수량 보고

사람들이 또한 지켜본다

뉴스

파트너 / 기고자

벤징가 글로벌